Paeonol

CAS No. 552-41-0

Paeonol( 2'-Hydroxy-4'-methoxyacetophenone | NSC 401442 )

Catalog No. M15001 CAS No. 552-41-0

Paeonol (Peonol), a phenolic compound extracted from Chinese herbs Paeonia suffruticosa (moutan cortex) and Cynanchum paniculatum, inhibits MAO with an IC50 of about 50 μM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
500MG 41 Get Quote
1G 58 Get Quote

Biological Information

  • Product Name
    Paeonol
  • Note
    Research use only, not for human use.
  • Brief Description
    Paeonol (Peonol), a phenolic compound extracted from Chinese herbs Paeonia suffruticosa (moutan cortex) and Cynanchum paniculatum, inhibits MAO with an IC50 of about 50 μM.
  • Description
    Paeonol (Peonol), a phenolic compound extracted from Chinese herbs Paeonia suffruticosa (moutan cortex) and Cynanchum paniculatum, inhibits MAO with an IC50 of about 50 μM.(In Vitro):Paeonol is found to be inhibitory against MAO A in a dose-dependent manner with IC50 value of 54.6 μM. Paeonol is shown to inhibit MAO-B in a dose-dependent manner with the IC50 of 42.5 μM. For Paeonol, the Ki is estimated to be 51.1 μM. The inhibition of Paeonol on MAO B is of competitive type with Ki value of 38.2 μM.(In Vivo):The 200 mg/kg Paeonol+I/R group [AN/V (%): 7.6±2.2, p<0.01] and 100 mg/kg Paeonol+I/R group [AN/V (%): 9.4±2.8, p<0.05] both show lesser extents of no-reflow area in the ventricles compared with the I/R group [AN/V (%): 18.2±2.9]. In particular, the 200 mg/kg Paeonol + I/R group experienced markedly alleviated no-reflow in the whole heart [AN/WH (%): 4.6±1, p<0.05] compared with the I/R group [AN/WH (%): 10.0±1.9].
  • In Vitro
    Paeonol is found to be inhibitory against MAO A in a dose-dependent manner with IC50 value of 54.6 μM. Paeonol is shown to inhibit MAO-B in a dose-dependent manner with the IC50 of 42.5 μM. For Paeonol, the Ki is estimated to be 51.1 μM. The inhibition of Paeonol on MAO B is of competitive type with Ki value of 38.2 μM.
  • In Vivo
    The 200 mg/kg Paeonol+I/R group [AN/V (%): 7.6±2.2, p<0.01] and 100 mg/kg Paeonol+I/R group [AN/V (%): 9.4±2.8, p<0.05] both show lesser extents of no-reflow area in the ventricles compared with the I/R group [AN/V (%): 18.2±2.9]. In particular, the 200 mg/kg Paeonol + I/R group experienced markedly alleviated no-reflow in the whole heart [AN/WH (%): 4.6±1, p<0.05] compared with the I/R group [AN/WH (%): 10.0±1.9].
  • Synonyms
    2'-Hydroxy-4'-methoxyacetophenone | NSC 401442
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    MAO
  • Recptor
    MAO-A| MAO-B
  • Research Area
    Neurological Disease
  • Indication
    ——

Chemical Information

  • CAS Number
    552-41-0
  • Formula Weight
    166.17
  • Molecular Formula
    C9H10O3
  • Purity
    >98% (HPLC)
  • Solubility
    Ethanol: 33 mg/mL (198.59 mM); DMSO: 33 mg/mL (198.59 mM)
  • SMILES
    CC(C1=CC=C(OC)C=C1O)=O
  • Chemical Name
    1-(2-Hydroxy-4-methoxyphenyl)ethanone

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Kong LD, et al. J Ethnopharmacol, 2004, 91(2-3), 351-355.
molnova catalog
related products
  • AnnH31

    AnnH31 is a potent Dyrk1A inhibitor with an IC50 value of 81 nM.AnnH31 inhibits MAO-A with an IC50 of 3.2 μM.AnnH31 can be used as a probe to confirm the involvement of DYRK1A in cellular phosphorylation.

  • Modaline sulfate

    Modaline, 2-methyl-3-piperidinopyrazine derivative, was found to inhibit monoamine oxidase (MAO) and showed therapeutic anti-depressant activity.

  • Esuprone

    Esuprone (LU-43839) is a novel reversible and highly selective MAO-A inhibitor with anticonvulsant activity for the treatment of depression.